| Name | Kinney Drugs #18 |
|---|---|
| Organization Name | Kph Healthcare Services Inc |
| Location | 164 Swanton Rd, Saint Albans, Vermont 05478 |
| Type | Pharmacy |
| Phone | (802) 524-6543 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Cellular Biomedicine Group, Inc. today announced the interim results of its Phase I/IIa clinical trial for human adipose-derived mesenchymal precursor cell (haMPC) therapy for Knee Osteoarthritis, which tests the safety and efficacy of intra-articular injections of autologous (patient's own) haMPCs in order to reduce inflammation and repair damaged joint cartilage.
The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.
"South Asia is facing a health crisis, with rising rates of heart disease, diabetes and obesity, and patients facing impoverishment as they pay for treatment out of their own pockets," according to a report released Wednesday by the World Bank, Reuters reports (Lyn, 2/9).
Some hot topics - the IPAB, the medical-loss ratio rule and the health law's impact on employer-sponsored health care - also claim headlines today. Meanwhile, MinnPost analyzes executive orders - including a controversial one on health care - by former Minnesota Gov. Tim Pawlenty, now a GOP presidential candidate.
› Verified 3 days ago
| NPI Number | 1326155508 |
| Organization Name | KPH HEALTHCARE SERVICES, INC. |
| Doing Business As | KINNEY DRUGS #18 |
| Type | Pharmacy |
| Address | 164 Swanton Rd, Saint Albans, VT 05478 |
| Phone Number | 802-524-6543 |
News Archive
Cellular Biomedicine Group, Inc. today announced the interim results of its Phase I/IIa clinical trial for human adipose-derived mesenchymal precursor cell (haMPC) therapy for Knee Osteoarthritis, which tests the safety and efficacy of intra-articular injections of autologous (patient's own) haMPCs in order to reduce inflammation and repair damaged joint cartilage.
The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.
"South Asia is facing a health crisis, with rising rates of heart disease, diabetes and obesity, and patients facing impoverishment as they pay for treatment out of their own pockets," according to a report released Wednesday by the World Bank, Reuters reports (Lyn, 2/9).
Some hot topics - the IPAB, the medical-loss ratio rule and the health law's impact on employer-sponsored health care - also claim headlines today. Meanwhile, MinnPost analyzes executive orders - including a controversial one on health care - by former Minnesota Gov. Tim Pawlenty, now a GOP presidential candidate.
› Verified 3 days ago
News Archive
Cellular Biomedicine Group, Inc. today announced the interim results of its Phase I/IIa clinical trial for human adipose-derived mesenchymal precursor cell (haMPC) therapy for Knee Osteoarthritis, which tests the safety and efficacy of intra-articular injections of autologous (patient's own) haMPCs in order to reduce inflammation and repair damaged joint cartilage.
The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.
"South Asia is facing a health crisis, with rising rates of heart disease, diabetes and obesity, and patients facing impoverishment as they pay for treatment out of their own pockets," according to a report released Wednesday by the World Bank, Reuters reports (Lyn, 2/9).
Some hot topics - the IPAB, the medical-loss ratio rule and the health law's impact on employer-sponsored health care - also claim headlines today. Meanwhile, MinnPost analyzes executive orders - including a controversial one on health care - by former Minnesota Gov. Tim Pawlenty, now a GOP presidential candidate.
› Verified 3 days ago
Hannaford Supermarket Pharmacy 8355 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 277 Swanton Rd, Saint Albans, Vermont 05478 Phone: (802) 524-2217 | |
Kinney Drugs #18 Type: Pharmacy Location: 164 Swanton Rd, Saint Albans, Vermont 05478 Phone: (802) 524-6543 | |
Price Chopper Pharmacy 127 Type: Pharmacy Location: 170 Swanton Rd, Saint Albans, Vermont 05478 Phone: (802) 524-2918 | |
Walmart Pharmacy 10-2332 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 700 Tuckers Way, Saint Albans, Vermont 05478 Phone: (802) 528-4118 | |
Walgreens #19795 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 133 N Main St, Saint Albans, Vermont 05478 Phone: (802) 524-2141 |